In the study, CT-26 KRASG12C mice cured by combination treatment of AMG510 and anti-PD-1 were rechallenged with CT-26 KRASG12C, parental CT-26 (KRASG12D), or 4 T1 (unrelated breast tumor model) tumor cells. The gene discussed is PDCD1; the disease is neoplasm.